VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
-2.89%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$58.7M
AUM Growth
+$58.7M
(-10%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.71B
| $32.6M | 55.55% | 498,558 | – | – |
|
|
GRTS
2
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $9.15M | 15.6% | 3,561,150 | – | – |
|
3
Passage Bio
PASG
$22.7M
| $6.2M | 10.57% | 4,959,769 | – | – |
|
4
Adverum Biotechnologies
ADVM
$64.6M
| $4.82M | 8.21% | 5,068,233 | – | – |
|
5
Aligos Therapeutics
ALGS
$73.3M
| $2.55M | 4.35% | 2,320,381 | – | – |
|
|
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
| $1.9M | 3.24% | 543,753 | – | – |
|
|
UTRS
7
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $1.33M | 2.27% | 1,673,700 | – | – |
|
|
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
| $121K | 0.21% | 101,855 | – | – |
|